Data were provided on the pharmaceutical quality, the tolerance of the product in dogs and the safety in humans (people in contact with the product) and the environment.
Ravimi kohta esitati järgmised andmed: farmatseutiline kvaliteet, koerte ravimitaluvus ja ravimi inimohutus (ohutus ravimiga kokkupuutuvatel inimestel) ning keskkonnaohutus.